Global Ablation Technologies Market 2012-2016:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Global Ablation Technologies Market 2012-2016 May 27th 2013, 00:00 TechNavio”s analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. TechNavio”s report, the Global Ablation Technologies market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Ablation Technologies … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98043. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/global-ablation-technologies-market-2012-2016-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Global Immunoassay Systems Market 2012-2016:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Global Immunoassay Systems Market 2012-2016 May 27th 2013, 00:00 TechNavio”s analysts forecast the Global Immunoassay Systems market to grow at a CAGR of 3.92 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased prevalence of chronic diseases worldwide. The Global Immunoassay Systems market has also been witnessing a growing popularity of portable immunoassays. However, limited reimbursements could pose a challenge to the growth of this market. TechNavio”s report, the Global Immunoassay Systems market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Immunoassay Systems market in the Americas, the … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98042. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/global-immunoassay-systems-market-2012-2016-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Confirm your unsubscription from 'Life Sciences Market Research Reports'

To confirm that you no longer wish to receive updates from 'Life Sciences Market Research Reports', please click on the following link:

http://blogtrottr.com/unsubscribe/confirm/NPw5Nk/2tFWGG


If you weren't expecting to receive this email, then simply ignore it and we'll go away.

Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU):Life Sciences Market Research Reports

Life Sciences Market Research Reports

Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU) May 29th 2013, 00:00 This report provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis - Review of the … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98829. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/diagnostic-testing-in-the-us-ancillary-hospital-locations-er-or-icu-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Emerging US Point-of-Care Testing Market: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Emerging US Point-of-Care Testing Market: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers May 29th 2013, 00:00 This report provides comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic instrument and reagent suppliers develop more effective business, R&D and marketing strategies. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of the emerging POC market segments, including their dynamics, trends, structure, size, … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98831. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/emerging-us-point-of-care-testing-market-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Diagnostic Testing in the US Physician Offices and Group Practices Supplier Shares and Sales Forecasts for Over 300 Tests:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Diagnostic Testing in the US Physician Offices and Group Practices Supplier Shares and Sales Forecasts for Over 300 Tests May 29th 2013, 00:00 This report provides comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic reagent and instrument suppliers develop more effective business, R&D and marketing strategies. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of the physician office/group practice diagnostics market, including its dynamics, trends, … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98830. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/diagnostic-testing-in-the-us-physician-offices-and-group-practices-supplier-shares-and-sales-forecasts-for-over-300-tests-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Competing in the US Point-of-Care Diagnostic Testing Market:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Competing in the US Point-of-Care Diagnostic Testing Market May 29th 2013, 00:00 This new report provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of the 10 major POC market segments, including their dynamics, trends, structure, … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98828. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/competing-in-the-us-point-of-care-diagnostic-testing-market-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

2013 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers:Life Sciences Market Research Reports

Life Sciences Market Research Reports

2013 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers May 29th 2013, 00:00 This new report provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of five POC market … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98832. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/2013-analysis-of-the-us-point-of-care-infectious-disease-diagnostics-market-physician-officesgroup-practices-emergency-rooms-ambulatory-care-centers-surgery-centers-birth-centers-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Oman Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Oman Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: Although one of the smallest healthcare markets in the Gulf Cooperation Council, Oman boasts a 10-year compound annual growth rate of 9% in US dollar terms, a figure in line with large regional players Saudi Arabia and the UAE. The reasons behind this are two-fold. Public and foreign private investment in the planning and construction of two US$1bn medical cities will see Oman become a regional medical tourism hub in the long term. Meanwhile, government policies will see the healthcare financial burden gradually shift towards the more lucrative private healthcare market with continuing foreign direct investment in the … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98779. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/oman-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Poland Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Poland Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: The Polish pharmaceutical market contracted severely in 2012 due to harsh pricing measures and strict margins imposed on wholesalers, pharmaceutical manufacturers and retailers. Moreover, over the course of the year, the burden of pharmaceutical spending shifted onto the Polish consumer, as the harsher reimbursement regime caused a rise in private contributions to prescription payments. We forecast a return to growth in 2013, driven by demand for hospitals and private consumption growth as the Polish government entrenches cuts to drug expenditure. We expect strong growth in the medium-to-long term as Poland’s economy diversifies and aligns with developed countries. The … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98784. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/poland-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Romania Insurance Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Romania Insurance Report Q3 2013 May 29th 2013, 00:00 BMI View: As of early 2013, our overall impression is that Romania’s insurance sector remains resilient in face of a number of challenges. In spite of the general softness of the economy in general and sales of cars in particular, there has not been a sharp contraction in non-life premiums. Premiums in the life segment have held up fairly well too, suggesting that – for those Romanians who can afford the regular premiums - life insurance is valued as a conduit for their savings. The Romania Insurance Report considers the prospects for life and non-life insurers in that country. As … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98787. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/romania-insurance-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Singapore Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Singapore Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: Unlike other developed Asia Pacific countries, we note that the Singaporean government is seeking to increase its share of healthcare expenditure in light of the ageing population’s rising demand for healthcare. Such commitment provides growth opportunities for pharmaceutical, health and health-related providers. We maintain that long-term growth potential will be limited by the small population in the country, but investors can make use of Singapore as a springboard to conduct business in the South East Asia region. Headline Expenditure Projections ? Pharmaceuticals: SGD940mn (US$770mn) in 2012 to SGD1.0bn (US$830mn) in 2013; +7.5% in local currency terms and +7.9% … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98791. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/singapore-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Lebanon Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Lebanon Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: Although Lebanon’s pharmaceutical market will remain largely valued by patented medicines consumption, we expect a swifter uptake in generic medicines over the 2012-2022 period. However, this generic drug uptake is jeopardised by the ongoing Syrian civil war. Syria’s civil unrest will continue to hinder pharmaceutical trade relations between Lebanon’s import-dependent medicines market and key drugmakers in Israel and Jordan, namely Teva Pharmaceuticals and Hikma Pharmaceuticals. Rising Lebanese political and economic instability, will also negatively impact consumption of locally produced and imported medicines. Headline Expenditure Projections ? Pharmaceuticals: LBP1,956bn (US$1.30bn) in 2012 to LBP2,038bn (US$1.36bn) in 2013; +4.2% in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98770. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/lebanon-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Bangladesh Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Bangladesh Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: While Bangladesh has a substantial population of 152mn people, annual per capita expenditure on healthcare is very modest at just US$28. Despite expected economic progress, the majority of the population will continue to have inadequate access to medicines and healthcare. Moreover, the country’s attractiveness to foreign players will continue to be limited due to shortcomings in its political and regulatory regimes, requiring aid organisations to increase their efforts in the country. However, there are weaknesses in the business environment, most notably a high level of corruption, which may limit the inflow of much-needed financial assistance. Headline Expenditure Projections … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98735. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/bangladesh-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Croatia Insurance Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Croatia Insurance Report Q3 2013 May 29th 2013, 00:00 As of early 2013, the general condition of Croatia’s insurance sector is similar to what it was a year ago. The non-life segment is fairly mature, competitive and constrained by the patchy economy. Life insurance premiums are growing – at low single-digit rates – although the risk aversion of Croatia’s investors and savers has reduced the popularity of unit-linked products. The government appears to be moving towards the sale of all or part of its 51% stake in market leader CROATIA Osiguranje. As of early 2013, the situation and short-term prospects of Croatia’s insurance sector remain fairly uninspiring. Official data … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98750. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/croatia-insurance-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Russia Insurance Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Russia Insurance Report Q3 2013 May 29th 2013, 00:00 At first glance, the prospects for Russia’s insurance sector appear quite exciting. By any standard, the Russian non-life segment is both large and rapidly growing. According to the Federal Financial Markets Service (FFMS), premiums increased by about one fifth in H112 relative to the previous corresponding period. Life premiums are surging, albeit from very low levels. The regulator has imposed new – and more stringent – capital requirements, which has contributed to the ongoing rationalisation of the insurance sector. Nevertheless, as of early 2013, it remains easy to identify weaknesses in the Russian insurance sector. Thus far, much of the … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98789. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/russia-insurance-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Canada Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Canada Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: The Canadian government’s focus on further cost-containment policies to healthcare overlooks the sector’s function as a generator of wealth. Canada’s healthcare sector, which receives 70% of its funding from the government, has absorbed labour forces during the economic downturn and indirectly created jobs for other sectors. It has also played an important role in contributing taxes and supporting other industries’ growth. We believe that, with household consumption remaining subdued and the overall economy still weak in the coming quarters, the Canadian government should reassess its healthcare policies and their potential impact on the Canadian economy. Headline Expenditure Projections … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98740. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/canada-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Tanzania Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Tanzania Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: Increased longevity in developed markets translates into an increased demand for aged care healthcare services and medicines. However, in emerging markets such as Tanzania, despite increased life expectancy, communicable diseases will remain a significant health burden over the next two decades - limiting revenue earning opportunities for companies whose product portfolios contain medicines for the treatment of long-term diseases. Headline Expenditure Projections ? Pharmaceuticals: TZS667.71bn (US$421mn) in 2012 to an anticipated TZS738.69bn (US$457mn) in 2013; +10.6% growth in local currency terms and +8.6% in US dollar terms. ? Healthcare: TZS2.72trn (US$1.71bn) in 2012 to TZS3.13trn (US$1.93bn) in 2013; … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98797. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/tanzania-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Portugal Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Portugal Pharmaceuticals and Healthcare Report Q3 2013 May 29th 2013, 00:00 BMI View: Portugal continues to struggle in the face of continued austerity measures, cuts and the financial obligations of its EU, ECB and IMF economic adjustment package, approved in May 2011. Its prospects deteriorated further in Q213, following the publication of PhRMA’s Special 301 Submission report for 2013. This has called for Portugal to be placed on the Priority Watch List, because of concerns such as that patent protection is not as robust as it should be, that pharmaceutical firms are finding launching products a lengthy process, and that reimbursement procedures are also subject to delays. This will do little … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98786. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/portugal-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Merrimack Pharmaceuticals, Inc. – Product Pipeline Review – 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Merrimack Pharmaceuticals, Inc. – Product Pipeline Review – 2013 May 27th 2013, 00:00 Merrimack Pharmaceuticals, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Merrimack Pharmaceuticals, Inc. – Product Pipeline Review – 2013″ provides data on the Merrimack Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Merrimack Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Merrimack Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98387. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/merrimack-pharmaceuticals-inc-product-pipeline-review-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Imaxio – Product Pipeline Review – 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Imaxio – Product Pipeline Review – 2013 May 27th 2013, 00:00 Imaxio – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Imaxio – Product Pipeline Review – 2013″ provides data on the Imaxio’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Imaxio’s corporate website, SEC filings, investor presentations and featured press releases, both from Imaxio and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Imaxio – Brief Imaxio overview including business description, key … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98400. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/imaxio-product-pipeline-review-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Hospira, Inc. – Product Pipeline Review – 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Hospira, Inc. – Product Pipeline Review – 2013 May 27th 2013, 00:00 Hospira, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Hospira, Inc. – Product Pipeline Review – 2013″ provides data on the Hospira, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Hospira, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Hospira, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Hospira, Inc. – Brief … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98282. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/hospira-inc-product-pipeline-review-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Debiopharm S.A. – Product Pipeline Review – 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Debiopharm S.A. – Product Pipeline Review – 2013 May 27th 2013, 00:00 Debiopharm S.A. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Debiopharm S.A. – Product Pipeline Review – 2013″ provides data on the Debiopharm S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Debiopharm S.A.’s corporate website, SEC filings, investor presentations and featured press releases, both from Debiopharm S.A. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Debiopharm S.A. – Brief … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98388. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/debiopharm-s-a-product-pipeline-review-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Camurus AB – Product Pipeline Review – 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Camurus AB – Product Pipeline Review – 2013 May 27th 2013, 00:00 Camurus AB – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Camurus AB – Product Pipeline Review – 2013″ provides data on the Camurus AB’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Camurus AB’s corporate website, SEC filings, investor presentations and featured press releases, both from Camurus AB and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Camurus AB – Brief … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98398. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/camurus-ab-product-pipeline-review-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Plexxikon Inc. – Product Pipeline Review – 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Plexxikon Inc. – Product Pipeline Review – 2013 May 27th 2013, 00:00 Plexxikon Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Plexxikon Inc. – Product Pipeline Review – 2013″ provides data on the Plexxikon Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Plexxikon Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Plexxikon Inc. and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Plexxikon Inc. – Brief … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98396. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/plexxikon-inc-product-pipeline-review-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions